(THER) Thrombolytics Flashcards

1
Q

What is the main endogenous activator of plasminogen and what is the end result?

A

t-PA I- single chain tissue plasminogen activator

Ultimately converts plasminogen into plasmin, allowing for dissolution of clots.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Physiologic Inhibitors of Plasminogen activation (main 2)

A
  1. PAI-1 (rapid acting plasminogen activator inhibitor)
  2. a2-antiplasmin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Plasminogen

A

Aka pro-fibrinolysin

It is the zymogenic form of the active enzyme plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does plasmin degrade?

A

Both fibrinogen and fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the product of plasmin’s action on fibrin?

A

D-dimers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fibrin is formed by the action of __________ on ___________.

A

Thrombin on fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Formed fibrin strands are stabilized by the action of ___________.

A

Factor XIIIa aka Transamidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the main (2) factors which promote Fibrinolysis?

A
  1. Plasminogen incroporation into thrombus via fibrin binding
  2. Binding of t-PA to fibrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factors which limit Fibrinolysis

A
  1. Fibrin crosslinking by Factor XIIIa
  2. Binding oof 2-antiplasmin to fibrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the (2) main clinically approved thrombolytic agents?

A
  1. Tissue plasminogen activators (both human t-Pa and the recombinants)
  2. Streptokinase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is thrombolytic therapy monitored?

A

There is no true monitoring of the effect on the clot. You must look at plasminogen/fibrinogen levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Main clinical uses of thrombolytic agents (6)

A
  1. Acute MI
  2. Periheral Arterial Occlusion
  3. DVT
  4. PE
  5. Thrombotic Stroke
  6. Catheter clearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacologic antagonists for thrombolytic agents (2)

A
  1. EACA (Epsilon-amino caproic acid)
  2. Tranexmic Acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Snake venom and thrombi

A

A number of venoms contain enzymes which can digest fibrinogen. Some are used therapeutically.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the first line anticoagulant during angioplasty?

A

Heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Streptokinase/Urokinase MOA and Route

A

Fibrinolytic

IV

17
Q

Streptokinase/Urokinase Indications and Side Effects

A

Ind: Thrombolysis, stroke, MI, PE

SE: Bleeding

18
Q

Tissue Plasminogen Activator MOA and Route

A

Fibrinolytic

IV

19
Q

Tissue plasminogen activator Indications and Side Effects

A

Ind: Thrombolysis, stroke, MI

SE: Bleeding

20
Q

Epsilon amino caproic acid (AMICAR) MOA and route

A

Anti-fibrinolytic

IV

21
Q

Epsilon amino caproic acid (AMICAR) Indications and Side Effects

A

Ind: Reversal of bleeding

SE: Hypotension

22
Q

Aprotinin (Trasylol) MOA and Route

A

Anti-fibrinolytic

IV

23
Q

Aprotinin (Trasylol) Indications and Side Effects

A

Ind: Reversal of bleeding

SE: graft thrombosis

24
Q

Ancrod MOA and Route

A

Fibrinolytic (derived from snake venom)

IV

25
Q

Ancrod Indications and Side Effects

A

Ind: Stroke

SE: Allergic reaction

26
Q

Tranexamic Acid (AMCHA) MOA and Route

A

Anti-fibrinolytic

IV

27
Q

Tranexamic Acid (AMCHA) Indications and Side Effects

A

Ind: Reversal of bleeding

SE: Retinopathy